inclusion criteria: * adults ≥18 years of age * positive ncov2 pcr test by nasopharyngeal, oral, saliva, or respiratory sample * clinical signs, symptoms, and respiratory status consistent with moderate covid-19 * score of 3-4 on the who ordinal scale * onset of moderate covid-19 symptoms ≤3 days of study enrollment * subject is in-patient at time of randomization to study treatment * subject or legally authorized representative is willing and able to provide informed consent, and agrees for subject to comply with planned study procedures including reproductive requirements.

inclusion criteria: * adults ≥18 years of age * positive ncov2 pcr test by nasopharyngeal, oral, saliva, or respiratory sample * clinical signs, symptoms, and respiratory status consistent with moderate covid-19 * score of 3-4 on the who ordinal scale * onset of moderate covid-19 symptoms ≤3 days of study enrollment * subject is in-patient at time of randomization to study treatment * subject or legally authorized representative is willing and able to provide informed consent, and agrees for subject to comply with planned study procedures including reproductive requirements.

inclusion criteria: adults ≥18 years of age positive ncov2 pcr test by nasopharyngeal, oral, saliva, or respiratory sample clinical signs, symptoms, and respiratory status consistent with moderate covid-19 score of 3-4 on the who ordinal scale onset of moderate covid-19 symptoms ≤3 days of study enrollment subject is in-patient at time of randomization to study treatment subject or legally authorized representative is willing and able to provide informed consent, and agrees for subject to comply with planned study procedures including reproductive requirements.

inclusion criteria: adults ≥18 years of age positive ncov2 pcr test by nasopharyngeal, oral, saliva, or respiratory sample clinical signs, symptoms, and respiratory status consistent with moderate covid-19 score of 3-4 on the who ordinal scale onset of moderate covid-19 symptoms ≤3 days of study enrollment subject is in-patient at time of randomization to study treatment subject or legally authorized representative is willing and able to provide informed consent, and agrees for subject to comply with planned study procedures including reproductive requirements.

inclusion criteria: - adults ≥18 years of age - positive ncov2 pcr test by nasopharyngeal, oral, saliva, or respiratory sample - clinical signs, symptoms, and respiratory status consistent with moderate covid-19 - respiratory status of spo2 > 94% and respiratory rate < 24 breaths/min without supplemental oxygen. - score of 3 on the who ordinal scale (hospitalized, no oxygen treatment) - symptom onset ≤3 days of study enrollment - subject is in-patient at time of randomization to study treatment subject or legally authorized representative is willing and able to provide informed consent

inclusion criteria: - adults ≥18 years of age - positive ncov2 pcr test by nasopharyngeal, oral, saliva, or respiratory sample - clinical signs, symptoms, and respiratory status consistent with moderate covid-19 - respiratory status of spo2 > 94% and respiratory rate < 24 breaths/min without supplemental oxygen. - score of 3 on the who ordinal scale (hospitalized, no oxygen treatment) - symptom onset ≤3 days of study enrollment - subject is in-patient at time of randomization to study treatment subject or legally authorized representative is willing and able to provide informed consent